CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $85.30 million. The enterprise value is -$21.69 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 78.26 million shares outstanding. The number of shares has increased by 19.68% in one year.
| Current Share Class | 78.26M |
| Shares Outstanding | 78.26M |
| Shares Change (YoY) | +19.68% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 58.94% |
| Float | 72.24M |
Valuation Ratios
The trailing PE ratio is 6.75.
| PE Ratio | 6.75 |
| Forward PE | n/a |
| PS Ratio | 0.72 |
| Forward PS | 1.13 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04
| Current Ratio | 1.04 |
| Quick Ratio | 1.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.88 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.33% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1.04M |
| Profits Per Employee | $113,361 |
| Employee Count | 122 |
| Asset Turnover | 0.70 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $1.23 million in taxes.
| Income Tax | 1.23M |
| Effective Tax Rate | 8.17% |
Stock Price Statistics
The stock price has decreased by -22.70% in the last 52 weeks. The beta is 1.03, so CTMX's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -22.70% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 49.29 |
| Average Volume (20 Days) | 1,688,697 |
Short Selling Information
The latest short interest is 4.39 million, so 5.61% of the outstanding shares have been sold short.
| Short Interest | 4.39M |
| Short Previous Month | 4.44M |
| Short % of Shares Out | 5.61% |
| Short % of Float | 6.08% |
| Short Ratio (days to cover) | 4.32 |
Income Statement
In the last 12 months, CTMX had revenue of $126.62 million and earned $13.83 million in profits. Earnings per share was $0.16.
| Revenue | 126.62M |
| Gross Profit | 126.62M |
| Operating Income | 6.71M |
| Pretax Income | 15.08M |
| Net Income | 13.83M |
| EBITDA | 8.55M |
| EBIT | 6.71M |
| Earnings Per Share (EPS) | $0.16 |
Full Income StatementBalance Sheet
The company has $117.59 million in cash and $10.60 million in debt, giving a net cash position of $106.99 million or $1.37 per share.
| Cash & Cash Equivalents | 117.59M |
| Total Debt | 10.60M |
| Net Cash | 106.99M |
| Net Cash Per Share | $1.37 |
| Equity (Book Value) | -23.45M |
| Book Value Per Share | -0.30 |
| Working Capital | 4.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$88.29 million and capital expenditures -$496,000, giving a free cash flow of -$88.78 million.
| Operating Cash Flow | -88.29M |
| Capital Expenditures | -496,000 |
| Free Cash Flow | -88.78M |
| FCF Per Share | -$1.13 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 5.30% and 10.92%.
| Gross Margin | 100.00% |
| Operating Margin | 5.30% |
| Pretax Margin | 11.89% |
| Profit Margin | 10.92% |
| EBITDA Margin | 6.75% |
| EBIT Margin | 5.30% |
| FCF Margin | n/a |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.68% |
| Shareholder Yield | -19.68% |
| Earnings Yield | 16.21% |
| FCF Yield | -104.08% |
Analyst Forecast
The average price target for CTMX is $5.77, which is 429.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.77 |
| Price Target Difference | 429.36% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 18.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -5.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.62 |
| Piotroski F-Score | 3 |